Abattis announces manufacturing partnership with Empirical Labs

Abattis Bioceuticals Corp., a specialty biotechnology company focused on cultivating, licensing and marketing proprietary ingredients, biosimilar compounds, equipment and consulting services to North American medicinal markets, has announced a manufacturing partnership with Empirical Labs.

This relationship will allow Abattis Bioceuticals Corp. the exclusive license for cannabidiol rich hemp oil products delivered directly to licensed physicians and dispensaries.

Empirical Labs is a high quality nutraceutical manufacturing facility. They specialise in Liposomal delivery of nutrients, a process that improves the absorption of phytochemicals by binding them to beneficial fats. This process will increase the delivery of phytocannabinoids in Abattis Cannabidiol-rich hemp oil from 50% to 90%.

In 1989, Herbalists Kelly and Nazreen Goyen started Empirical Labs. As natural health enthusiasts they used their own experiences in healing to help shape Empirical Labs. Their work towards providing high quality nutraceutical products for doctors and consumers quickly earned them a reputation as having a keen sense of quality when selecting herbs, extracts, vitamins and minerals.

Dr Emek Blair, PhD, oversees our R&D and Quality Assurance. He earned his undergraduate degree from Occidental College and performed his graduate work in bioanalytical chemistry at the University of California, Irvine. Dr Blair developed the proprietary and cutting edge liposome technology used at Empirical Labs to formulate and manufacture its highly effective liposomal product line.